RemSleep Holdings (RMSL) Assets Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -53.42% |
| Sep 30, 2025 | -50.26% |
| Jun 30, 2025 | -49.19% |
| Mar 31, 2025 | -47.62% |
| Dec 31, 2024 | -44.70% |
| Sep 30, 2024 | -31.18% |
| Jun 30, 2024 | 31.95% |
| Mar 31, 2024 | 60.56% |
| Dec 31, 2023 | 73.58% |
| Sep 30, 2023 | 115.98% |
| Jun 30, 2023 | 145.12% |
| Mar 31, 2023 | 99.44% |
| Dec 31, 2022 | 136.74% |
| Sep 30, 2022 | 167.36% |
| Jun 30, 2022 | 147.29% |
| Mar 31, 2022 | 233.72% |
| Dec 31, 2021 | 294.29% |
| Sep 30, 2021 | 207.77% |
| Jun 30, 2021 | 23.84% |
| Mar 31, 2021 | 33.40% |
| Dec 31, 2020 | 7.87% |
| Sep 30, 2020 | 192.42% |
| Jun 30, 2020 | 106.89% |
| Mar 31, 2020 | 210.29% |
| Dec 31, 2019 | 170.17% |
| Sep 30, 2019 | 121.82% |
| Jun 30, 2019 | 146.12% |
| Mar 31, 2019 | 82.58% |
| Dec 31, 2018 | 44.62% |
| Sep 30, 2018 | 64.98% |
| Jun 30, 2018 | 133.43% |
| Mar 31, 2018 | 80.29% |
| Dec 31, 2017 | 116.85% |
| Sep 30, 2016 | 1,080.49% |
| Jun 30, 2016 | 387.58% |
| Mar 31, 2016 | 198.41% |
| Dec 31, 2015 | 240.50% |
| Sep 30, 2015 | 200.46% |
| Jun 30, 2015 | -13.26% |
| Mar 31, 2015 | 26.71% |
| Dec 31, 2014 | 13.40% |